Actively Recruiting

Phase Not Applicable
Age: 15Years - 18Years
All Genders
NCT06441786

A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism

Led by Uppsala University · Updated on 2025-09-29

36

Participants Needed

1

Research Sites

106 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this open clinical trial is to try out and evaluate a group metacognitive treatment protocol, for adolescents aged 15-18 years of age with anxiety and/or depression and an autism diagnosis. The main questions it aims to answer are: 1. How does the recruitment to the study work and what is the retention rate? 2. What is the level of participant compliance? 3. Is the treatment adherence satisfactory, are there any practical problems with treatment delivery? 4. Are the outcome measures and assessment procedures feasible? 5. Do the participants accept the treatment, are there any reports of adverse effects? 6. What are the preliminary effects of the treatment regarding 1. Symptoms of anxiety and/or depression 2. Quality of life 3. Functional impairment 4. Subjective level of stress 5. Central metacognitive processes 7. Are changes in metacognitive processes related to changes in anxiety and depression? The participants will partake in metacognitive group treatment of 10 sessions following an initial screening.

CONDITIONS

Official Title

A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism

Who Can Participate

Age: 15Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age of 15 to 18 years
  • Seeking medical care at PRIMA psychiatric clinic for children and youth in Stockholm
  • Diagnosed with anxiety disorder or depression and autism through clinical interview
  • Able to understand and participate in Swedish language treatment
  • Willing and able to participate after receiving study information
Not Eligible

You will not qualify if you...

  • Diagnosed with bipolar syndrome, alcohol or substance use syndromes, psychotic symptoms, affective syndromes with psychotic symptoms, or antisocial personality disorder
  • High risk of suicide
  • Extensive self-harm behavior or moderate to high risk of self-harm
  • Currently receiving or about to start other psychological treatment during the study period
  • Not on stable medication for the past month or planning medication changes during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

PRIMA Child and Youth Psychiatry, Handen

Haninge, Stockholm County, Sweden, 13640

Actively Recruiting

Loading map...

Research Team

T

Timo Hursti, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here